Imricor Medical Systems, Inc.

Equities

IMR

AU0000054942

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 08:55:32 2024-05-20 pm EDT			5-day change	1st Jan Change
0.445 ^AUD	-1.11%		-2.20%	-21.93%

May. 15	Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call
May. 09	Imricor Medical Systems' VISABL-AFL Trial Receives Final Clearance from Swissmedic	MT

Imricor Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022

February 22, 2023 at 04:49 pm EST

Imricor Medical Systems, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 0.816 million compared to USD 0.696 million a year ago. Net loss was USD 17.36 million compared to USD 19.73 million a year ago.

Latest news about Imricor Medical Systems, Inc.

Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call	May. 14
Imricor Medical Systems' VISABL-AFL Trial Receives Final Clearance from Swissmedic	May. 08	MT
Imricor Medical Systems Announces Release of Certain Stocks from Voluntary Escrow	May. 01	MT
Transcript : Imricor Medical Systems, Inc., Q1 2024 Earnings Call, Apr 30, 2024	Apr. 29
Imricor Medical Systems Secures First Catheter Order from Croatia's Dubrava University Hospital	Apr. 10	MT
Mining, Healthcare Stocks Lift Australian Benchmark	Apr. 10	MT
Imricor Medical Systems Gains Approval for Clinical Trial at Cardiovascular Institute of South Paris; Shares Up 7%	Apr. 09	MT
Amsterdam University Medical Center Resumes Atrial Flutter Procedures with Imricor's NorthStar Mapping System	Apr. 04	MT
Imricor Medical Systems Completes AU$6.4 Million Shortfall Share Issue	Apr. 02	MT
Imricor Medical Systems' NorthStar 3D Mapping System Obtains Approval for Use in VISABL-AFL Trial	Mar. 25	MT
Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call	Mar. 18
Imricor Medical Systems Secures Ethics Approval for Imaging Device Trial; Shares Rise 4%	Mar. 10	MT
Imricor Medical Systems' VISABL-AFL Trial Obtains Lausanne University Hospital Ethics Approval; Shares Up 8%	Mar. 07	MT
Imricor's Diagnostic Catheter Granted CE Mark Approval for European Market Sales; Shares Decline 4%	Mar. 05	MT
Transcript : Imricor Medical Systems, Inc., 2023 Earnings Call, Mar 05, 2024	Mar. 04
Imricor Medical Systems' Loss Widens in 2023; Shares Down 8%	Feb. 28	MT
Imricor Medical Systems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Imricor Medical Systems Plans Up to AU$15 Million Placement, Entitlement Offer	Feb. 02	MT
Imricor Medical Systems Secures Approval to Start US Medical Device Trial	Jan. 18	MT
Imricor Gets Approval from Saudi Food and Drug Authority for ICMR Cardiac Ablation Products	Jan. 10	MT
Imricor Medical Systems Signs Distribution Agreement with Qatar's East Agency WWL	Dec. 19	MT
Imricor Medical Systems Signs Deal to Incorporate AI Modules to Heart Mapping System	Nov. 28	MT
Imricor Medical Raises AU$4.3 Million from Share Placement	23-10-25	MT
Imricor Medical Systems Activates New iCMR Site in Croatia	23-10-12	MT
Imricor Medical Systems Draws Down Nearly AU$300,000 from AU$30 Million Facility	23-09-29	MT

Chart Imricor Medical Systems, Inc.

Duration

Period

More charts

Company Profile

Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging (MRI)-compatible medical devices, which is used to carry out real-time interventional Cardiac Magnetic Resonance Imaging (iCMR) cardiac ablation procedures. The Company is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The Company sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.3005 USD

Average target price

0.628 USD

Spread / Average Target

+108.97%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
IMRICOR MEDICAL SYSTEMS, INC.	-21.93%	60.87M
THERMO FISHER SCIENTIFIC	+10.89%	227B
DANAHER CORPORATION	+14.69%	198B
INTUITIVE SURGICAL, INC.	+18.59%	142B
BOSTON SCIENTIFIC CORPORATION	+31.00%	111B
SIEMENS HEALTHINEERS AG	+0.80%	64.16B
EDWARDS LIFESCIENCES CORPORATION	+18.85%	54.1B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+5.82%	51.41B
AGILENT TECHNOLOGIES, INC.	+10.01%	45.32B
GE HEALTHCARE TECHNOLOGIES INC.	+5.37%	37.32B

Other Advanced Medical Equipment & Technology